Ulka N. Vaishamayan

Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

Nils Kroeger, Wanling Xie, Jae‐Lyn Lee et al. · Cancer · 2013 · 232 citations · Full text

Medicine, Oncology, Genitourinary Oncology +15

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

Laurence Albigès, A. Ari Hakimi, Wanling Xie et al. · Journal of Clinical Oncology · 2016 · 216 citations

Medicine, Cancer Biology, Oncology +17

Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy

Nils Kroeger, Toni K. Choueiri, Jae-Lyn Lee et al. · European Urology · 2013 · 82 citations · Full text

Medicine, Nephrology, Oncology +17

Characteristics of Long-Term and Short-Term Survivors of Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: Results From the International mRCC Database Consortium

André P. Fay, Wanling Xie, Jae-Lyn Lee et al. · Clinical Genitourinary Cancer · 2014 · 13 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +13